Page last updated: 2024-08-26

bosentan anhydrous and Dermatosclerosis

bosentan anhydrous has been researched along with Dermatosclerosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aranegui, B; Jiménez-Reyes, J	1
Bernal, M; De Cata, A; De Cosmo, S; Inglese, M; Mazzoccoli, G; Molinaro, F; Rubino, R	1
Enk, A; Hartmann, M; Hartschuh, W; Haust, M; Klein, S; Krammer, PH; Kretz, CC; Kuhn, A; Oberle, N; Ruland, V; Stumpf, C; Suri-Payer, E	1
Varga, J	1
Castro, Mdel C; Collantes, E; Miranda, MD; Moreno, JC; Morote, G; Roldan, R	1

Reviews

1 review(s) available for bosentan anhydrous and Dermatosclerosis

Article	Year
Morphea in Childhood: An Update. Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:4 Topics: Acute-Phase Proteins; Bosentan; Calcitriol; Child; Child, Preschool; Female; Humans; Imiquimod; Immunosuppressive Agents; Incidence; Male; Phototherapy; Prevalence; Prognosis; Quality of Life; Scleroderma, Localized; Vitamin D	2018

Trials

1 trial(s) available for bosentan anhydrous and Dermatosclerosis

Article	Year
New hope for systemic sclerosis patients with digital ulcers. Current rheumatology reports, 2005, Volume: 7, Issue:2 Topics: Administration, Oral; Bosentan; Chemical and Drug Induced Liver Injury; Double-Blind Method; Endothelin Receptor Antagonists; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Scleroderma, Localized; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Toes; Treatment Outcome	2005

Article

Year

New hope for systemic sclerosis patients with digital ulcers.

Current rheumatology reports, 2005, Volume: 7, Issue:2

Topics: Administration, Oral; Bosentan; Chemical and Drug Induced Liver Injury; Double-Blind Method; Endothelin Receptor Antagonists; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Scleroderma, Localized; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Toes; Treatment Outcome

2005

Other Studies

3 other study(ies) available for bosentan anhydrous and Dermatosclerosis

Article	Year
Digital ulcers in scleroderma patients: A retrospective observational study. International journal of immunopathology and pharmacology, 2016, Volume: 29, Issue:2 Topics: Adult; Bosentan; Female; Fingers; Humans; Iloprost; Leg; Male; Middle Aged; Retrospective Studies; Scleroderma, Localized; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing	2016
Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Annals of the rheumatic diseases, 2011, Volume: 70, Issue:8 Topics: Adult; Aged; Biopsy; Bosentan; Case-Control Studies; CD4-Positive T-Lymphocytes; Dermatitis; Dermatologic Agents; Endothelin A Receptor Antagonists; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Male; Middle Aged; Scleroderma, Localized; Scleroderma, Systemic; Skin; Sulfonamides; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory	2011
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children. The Journal of rheumatology, 2006, Volume: 33, Issue:12 Topics: Antihypertensive Agents; Bosentan; Child, Preschool; Contracture; Disabled Children; Female; Humans; Scleroderma, Localized; Skin Ulcer; Sulfonamides; Treatment Outcome	2006